Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Retinitis pigmentosa
100%
Retinal Degeneration
90%
Pupillometer
84%
Retinal Function
77%
Pupil Response
73%
Visual Field
70%
Pupil Contraction
57%
Rat Model
56%
Royal College of Surgeons Rat
56%
Mouse Model
54%
Fibroblast Growth Factor 7 (FGF7)
53%
Retina
52%
Optical Coherence Tomography
51%
Human Mesenchymal Stem Cells (hMSCs)
50%
Retinal Dystrophy
45%
Visual Field Defect
40%
Chromatic Perimetry
39%
Objective Perimetry
39%
Fibroblast Growth Factor 2 (FGF2)
34%
Cis-carotene
33%
Repetitive Transcranial Magnetic Stimulation (rTMS)
33%
Bioactive
33%
Human Serum Albumin Nanoparticles
33%
Epithelial Ovarian Carcinoma
33%
Alternative Splicing
33%
Ovarian Carcinoma Cells
33%
Receptor Binding
33%
Israeli Population
33%
Inherited Retinal Disease
33%
Objective Diagnosis
33%
Vascular Endothelial Growth Factor
33%
Extravascular Space
33%
Visual Acuity
33%
Contraction Velocity
33%
Fibroblast Growth Factor 1 (FGF1)
32%
Light Stimulus
32%
Iron Oxide
31%
Spectral Domain Optical Coherence Tomography (SD-OCT)
31%
Red Light
30%
Fundus Imaging
30%
Protease-activated Receptor 1 (PAR1)
29%
Fibroblast Growth Factor Receptor 1 (FGFR1)
29%
Blue Light
29%
Photoreceptor
27%
Latency
27%
Long Wavelength
27%
Electroretinography
26%
Indocyanine Green
23%
Biological Activity
23%
Beta Wave
23%
Medicine and Dentistry
Retinitis pigmentosa
90%
Optical Coherence Tomography
87%
Retina Degeneration
81%
Choroid
78%
Extravascular Space
67%
Visual Field Test
62%
Electroretinography
56%
Photoreceptor
54%
Surgeon
53%
Spectral Domain Optical Coherence Tomography
51%
Visual Field
48%
Injection
48%
Retina Dystrophy
46%
Diseases
40%
Alzheimer's Disease
33%
Glaucoma
33%
Carcinoma Cell
33%
Krukenberg Tumor
33%
Carotene
33%
Retina Disease
33%
Indocyanine Green
33%
Fundus Imaging
31%
Visual Acuity
30%
Visual Field Defect
30%
Fluorescein
30%
Intraocular Pressure
29%
Clinical Trial
26%
Therapy Effect
26%
Autofluorescence
25%
Agents Acting on the Eye
24%
Posterior Pole
23%
Bone Marrow Mesenchymal Stem Cell
23%
Outer Nuclear Layer
23%
Vision
22%
Prevalence
21%
Best Corrected Visual Acuity
21%
Stem Cell
21%
Myopia
21%
Retinopathy
20%
Leber Congenital Amaurosis
20%
Cornea Erosion
19%
Corneal Epithelium
19%
Mean Corpuscular Volume
19%
Middle Age
19%
Retinoid
18%
Area under the Curve
17%
Magnetic Stimulation
16%
Bevacizumab
16%
Pupillary Response
16%
Specific-Pathogen-Free
16%